Campath-1G in vivo confers a low incidence of graft-versus-host disease associated with a high incidence of mixed chimaerism after bone marrow transplantation for severe aplastic anaemia using HLA-identical sibling donors.

Eitemau Tebyg

• EVALUATION OF OUTCOME AND CHIMERIC STATUS FOLLOWING HLA IDENTICAL SIBLING BONE-MARROW TRANSPLANTATION FOR SEVERE APLASTIC-ANEMIA USING IN-VIVO CAMPATH-1G
  gan: Hamblin, M, et al.
  Cyhoeddwyd: (1995)
• Long-term outcome after marrow transplantation from HLA-identical sibling donors for acquired aplastic anaemia using cyclophosphamide and in-vivo anti-CD52 monoclonal antibodies
  gan: Gupta, V, et al.
  Cyhoeddwyd: (2005)
• Favourable impact on acute and chronic graft-versus-host disease with cyclophosphamide and in-vivo anti-CD52 monoclonal antibodies for marrow transplantation from HLA-identical sibling donors for acquired aplastic anaemia.
  gan: Gupta, V, et al.
  Cyhoeddwyd: (2004)
• Favorable effect on acute and chronic graft-versus-host disease with cyclophosphamide and in vivo anti-CD52 monoclonal antibodies for marrow transplantation from HLA-identical sibling donors for acquired aplastic anemia.
  gan: Gupta, V, et al.
  Cyhoeddwyd: (2004)
• P1286: MIXED CHIMAERISM IS ASSOCIATED WITH POORER LONG-TERM FAILURE-FREE SURVIVAL AMONG APLASTIC ANAEMIA PATIENTS RECEIVING HLA-MATCHED DONOR TRANSPLANTATION
  gan: Zhengli Xu, et al.
  Cyhoeddwyd: (2023-08-01)